Manufacturing / Medicinal Chemicals
MediWound Ltd.
MDWD
$12.54
+$0.15 (+1.23%)
Price as of Oct 9, 2026 19:32 UTC
170 M
Market Cap (Micro Cap)
Nov 18
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $13.48
- Above 50-day average $13.68
- Above 200-day average $15.55 · -17.4%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 182d ago
Volume
- Below-average volume 0.9x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for MDWD options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
7 buys
4 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Sep 01, 2026 | Rubinstein Samuel | Sell | 525 | $6,678 | -2.4% | |
| Sep 01, 2026 | Rubinstein Samuel | Buy | 525 | $6,626 | -1.6% | |
| Aug 27, 2026 | Hess Shmuel | Sell | 1,979 | $25,173 | -2.4% | |
| Aug 27, 2026 | Hess Shmuel | Exercise | 11,000 | $0 | -6.2% | |
| Aug 27, 2026 | Hess Shmuel | Sell | 1,979 | $25,976 | -5.4% | |
| Aug 26, 2026 | Hess Shmuel | Exercise | 5,000 | $0 | -2.2% | |
| Aug 26, 2026 | Hess Shmuel | Sell | 1,865 | $24,245 | -4.5% | |
| Jun 03, 2026 | SHAMIR NACHUM | Buy | 5,825 | $81,550 | -11.3% | |
| Jun 03, 2026 | SHAMIR NACHUM | Buy | 175 | $2,446 | -11.1% | |
| Jun 03, 2026 | SHAMIR NACHUM | Other | 5,825 | $81,550 | -11.3% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 19, 2026 | Q2 2026 | -$0.78 | |||
| Aug 13, 2026 | Q2 2026 | -$0.78 | |||
| Aug 12, 2026 | Q2 2026 | -$0.78 | |||
| Jun 30, 2026 | Q2 2026 | -$0.78 | -$0.77 | +0.9% | Beat |
| May 27, 2026 | Q1 2026 | -$0.67 | |||
| Mar 31, 2026 | Q1 2026 | -$0.67 | -$0.23 | +65.6% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.64 | -$0.56 | +13.1% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.83 | -$0.24 | +71.0% | Beat |
Track MDWD with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MDWD and your entire portfolio.